secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXOZYMES INC. (EXOZ)
CIK:        0002010788
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0001641172-25-016681
Event type: other_material
Sentiment:  positive
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

eXoZymes to receive $3M from NSF as key partner in $9.2M cell-free biomanufacturing initiative
--------------------------------------------------------------------------------

- Selected as core industrial partner in Meta-PURE, a $9.2M NSF-funded project under CFIRE program.
- eXoZymes awarded approximately $3M share to develop a cell-free ATP-generating module and a santalene production module.
- Project led by Georgia Tech; coalition includes academic and industry groups; starts July 1, 2025, for three years.
- eXoZymes' technology enables plug-and-play modular cell-free biomanufacturing for multiple market-relevant targets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2010788/000164117225016681/0001641172-25-016681-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2010788/000164117225016681/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-016681

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer